T. Rowe Price Investment Management, Inc. Applied Therapeutics Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 18,683,990 shares of APLT stock, worth $8.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,683,990
Previous 10,380,590
79.99%
Holding current value
$8.22 Million
Previous $5.08 Million
14.13%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
Vestal Point Capital, LP New York, NY11.5MShares$5.06 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.97 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.43 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$2.08 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $21.1M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...